Contact Us

Focus

TikTok "Refugees" Flock to U.S. Owned Rival, Triller

High-Profile Creators Migrate to Triller as Platform Poised to Become 2025\'s Leading Short-Form Video App

Focus

Jan 21, 2025

TTA and ISO Join Forces to Revolutionize Global Horticulture and Food Production

GORINCHEM,Netherlands,Jan. 20,2025-- In a groundbreaking step for the horticultural industry,ISO Horti—a specialist in horticultural robotics and automation—and TTA—experts in transplanting and so

Focus

Jan 21, 2025

Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC

Indonesia,Malaysia,Philippines,India and Singapore record massive smartphone user bases KUALA LUMPUR,Jan. 20,2025-- Global cloud communication platform,Infobip has unveiled a new report titled \'RCS:

Focus

Jan 21, 2025

CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI,Jan. 20,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

Focus

Jan 21, 2025

DAHON Unveils Groundbreaking D-VELO Speed Technology at CABDA 2025 in New York

NEW YORK,Jan. 21,2025-- On January 15,theCABDA EAST Expo kicked off at the Meadowlands Exposition Center in New York,where DAHON unveiled its new "D-VELO" technology,captivating the interest

Focus

Jan 21, 2025

YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia

SHANGHAI,Jan. 21,2025--YolTech Therapeutics,a clinical-stage gene editing company dedicated to delivering lifelong cures,announced the initiation of a clinical trial for YOLT-204,an investigational th

Focus

Jan 21, 2025
1 ... 104 105 106 107 108 109 110 ... 120